학술논문
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
Document Type
Article
Author
Source
In Osteoporosis and Sarcopenia March 2020 6(1):15-19
Subject
Language
ISSN
2405-5255